![]() Unlike targeted therapies that attempt to regulate specific mutations within cancer, our therapeutic approach is designed to take advantage of a cancer cell’s innate metabolic weaknesses to compromise its defenses, leading to cell death through oxidative stress and exposure to the body’s natural immune system. is a clinical-stage biotechnology company developing cancer therapeutics that are intended to be broadly effective across tumor types and have low toxicity profiles. To obtain a hi-resolution photograph of the Market Open, please go to and click on the market open of your choice. ![]() Nasdaq MarketSite – 4 Times Square – 43 rd & Broadway – Broadcast Studioįor multimedia features such as exclusive content, photo postings, status updates and video of bell ceremonies, please visit our Facebook page:įor photos from ceremonies and events, please visit our Instagram page:įor livestream of ceremonies and events, please visit our YouTube page:įor news tweets, please visit our Twitter page:įor exciting viral content and ceremony photos, please visit our Tumblr page:Ī live stream of the Nasdaq Opening Bell will be available at: In honor of the occasion, Tyme Co-founders Steven Hoffman, CEO & Chief Science Officer, and Michael Demurjian, Chief Operating Officer, will ring the Opening Bell. ![]() (Nasdaq:TYME), a clinical stage biotechnology company developing novel cancer therapeutics to address multiple tumor types, will visit the Nasdaq MarketSite in Times Square in celebration of their recent IPO.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |